Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.
about
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaAssessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in JapanToxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDInvolvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesAcetaldehyde-derived advanced glycation end-products promote alcoholic liver diseaseIn vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada diseaseGlyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cellsOxidative stress in diabetes and Alzheimer's disease.Amyloid-β production: major link between oxidative stress and BACE1.Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration.Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.Protein modification by dicarbonyl molecular species in neurodegenerative diseases.Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-productsOxidative damage in the liver of rats treated with glycolaldehyde.Immunological detection of fructose-derived advanced glycation end-products.Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons.Proteomic and immunochemical approaches to understanding the glycation behaviour of the casein and β-lactoglobulin fractions of flavoured drinks under UHT processing conditions
P2860
Q26747425-A15BB45A-8222-4BA0-B096-77E00E377EBDQ26781477-DDEBA4E5-E341-47FA-A05C-387A3F1E46BBQ28543766-88BA1044-6BDD-4201-A240-2D2FE82C4FACQ33852213-925616B2-76AE-428D-8BE3-098D108959C3Q34728267-23E41BB0-7D2D-49C9-9FEF-08945586B303Q34905489-FD529174-C09D-4FAB-82CA-88C85B6DE67FQ35561941-5F22E82A-0D9B-466A-ACB8-F9C30B55C759Q35593900-656B1D2E-8340-4D7F-95D6-D0D2B1EE9C00Q35993403-BC438636-29E2-444C-8FC3-6BA3987EB92DQ37455830-3A1C7361-D011-4F22-B018-581BAEDD9C56Q37946306-B48DDDDC-4C95-46AA-ACAB-AC312DA21935Q38359414-FB03E3F5-BA65-4824-8F8A-9F9A9974EB49Q39398227-1DD18063-DFAC-49CC-8CBA-1FBF1499E41AQ40683231-CA79EFD5-0664-482D-ADEA-1EACB5834C7CQ40973301-F75ED089-8EA5-4C54-A0A6-6B60C0031AACQ41789363-5B0D0E9F-93DA-4815-8907-69EE06E488E5Q42734294-D4D1BDD3-AEE8-456D-B047-02977E25C06CQ42747339-83D5919C-2407-4DCB-A646-DBA74B38FEC7Q43138020-043DE47D-3FEB-4C58-80F4-A3251A2C0385Q44455399-40A4D933-C861-4DF1-BC1C-99D91294AFE4Q58701396-51FE63DE-F0FD-4595-AB0C-2C0C846620E3
P2860
Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alternative routes for the for ...... lycation end-products in vivo.
@ast
Alternative routes for the for ...... lycation end-products in vivo.
@en
Alternative routes for the for ...... lycation end-products in vivo.
@nl
type
label
Alternative routes for the for ...... lycation end-products in vivo.
@ast
Alternative routes for the for ...... lycation end-products in vivo.
@en
Alternative routes for the for ...... lycation end-products in vivo.
@nl
prefLabel
Alternative routes for the for ...... lycation end-products in vivo.
@ast
Alternative routes for the for ...... lycation end-products in vivo.
@en
Alternative routes for the for ...... lycation end-products in vivo.
@nl
P356
P1476
Alternative routes for the for ...... lycation end-products in vivo.
@en
P2093
P304
P356
10.2174/1566524013363735
P577
2001-07-01T00:00:00Z